1-3 of 3
Sidney M Morris, Jr., PhD
Close
Sort by
Journal Articles

Eculizumab Reduces Pulmonary Hypertension through Inhibition of Hemolysis-Associated Nitric Oxide Consumption in Patients with Paroxysmal Nocturnal Hemoglobinuria

Anita Hill, MD, Russell P. Rother, PhD, Xunde Wang, MD, Robert J Sapsford, MD, Paul O Collinson, MD, David C Gaze, PhD, Sidney M Morris, Jr., PhD, Andrew Scally, Kerry Quinn-Senger, PhD, Stephen J Richards, PhD, Monica Bessler, MD, PhD, Richard Kelly, MD, Peter Hillmen, MBChB, PhD, Mark Gladwin, MD
Journal: Blood
Blood (2008) 112 (11): 486.
https://doi.org/10.1182/blood.V112.11.486.486
Published: 2008
Journal Articles

Lactate Dehydrogenase as a Biomarker of Hemolysis-Associated Nitric Oxide Resistance, Priapism, Leg Ulceration, Pulmonary Hypertension and Death in Patients with Sickle Cell Disease.

Gregory J. Kato, MD, Vicki McGowan, BS, Roberto F. Machado, MD, Jane A. Little, MD, James Taylor, VI, MD, Claudia R. Morris, MD, James S. Nichols, RN, Xunde Wang, PhD, Mirjana Poljakovic, PhD, Sidney M. Morris, Jr., PhD, Mark T. Gladwin, MD
Journal: Blood
Blood (2005) 106 (11): 3188.
https://doi.org/10.1182/blood.V106.11.3188.3188
Published: 2005
Journal Articles

The Arginine-to-Ornithine Ratio: Biomarker of Arginase Activity and Predictor of Mortality in Sickle Cell Disease.

Claudia R. Morris, MD, Gregory Kato, MD, Mirjana Poljakovic, PhD, William C. Blackwelder, Stan Hazen, MD, PhD, Elliott P. Vichinsky, MD, Sidney M. Morris, Jr., PhD, Mark T. Gladwin, MD
Journal: Blood
Blood (2004) 104 (11): 237.
https://doi.org/10.1182/blood.V104.11.237.237
Published: 2004